Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CDK5–p35 complex is a neuron-specific serine/threonine kinase complex in which the p35 regulatory subunit activates cyclin-dependent kinase 5 (CDK5). Unlike other cyclin-dependent kinases, CDK5 is not involved in cell cycle regulation but in neuronal migration, differentiation, axon guidance, and synaptic function. p35 is necessary for the activation of CDK5 in post-mitotic neurons, guiding its subcellular localization and enabling its function in the developing and mature brain. Disruption of the CDK5–p35 axis, such as the production of the aberrant activator p25 (truncated from p35), is implicated in neurodegenerative pathologies like Alzheimer's disease, due to the deregulation of kinase activity and subsequent hyperphosphorylation of neuronal substrates.
Inhibition of CDK5 kinase activity (typically by blocking ATP-binding or by disrupting p35 binding). Modulation of p35 phosphorylation, processing, or destruction.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin-dependent kinase 5 (with p35 regulatory subunit) (CDK5–p35).